The Centers for Disease Control and Prevention yesterday issued a health advisory warning of an uptick over the last year in meningococcal disease in which isolates show the gene associated with penicillin resistance and mutations associated with ciprofloxacin resistance.

CDC said the majority of cases were in Hispanic individuals.

The agency recommends the following for providers and clinicians:

  • Health care providers should perform antimicrobial susceptibility testing to determine susceptibility of all meningococcal isolates to penicillin before changing from empirical treatment with cefotaxime or ceftriaxone to penicillin or ampicillin.
  • In states that have experienced meningococcal disease cases caused by ciprofloxacin-resistant strains within the past 1–2 years, clinicians and public health staff should consider AST on meningococcal isolates to inform prophylaxis decisions. AST should not delay the initiation of prophylaxis with ciprofloxacin, rifampin or ceftriaxone.

Related News Articles

Headline
The AHA, Association of American Medical Colleges and Catholic Health Association of the United States today requested the Department of Treasury and the…
Headline
The Department of Health and Human Services yesterday announced the reestablishment of the Ready Reserve Corps, a uniformed services that provides trained and…
Headline
Loyola Medicine has maintained a strong partnership with its neighboring communities in Chicago’s near western suburbs. Prior to the COVID-19 pandemic, this…
Headline
Each June “What Matters to You?” Day aims to encourage meaningful conversations between people who provide and receive health and social care. The AHA will…
Chairperson's File
June 5 is the fourth annual Hospitals Against Violence Hope (#HAVhope) Friday. This year’s national day of awareness, which is taking place as protests against…
Headline
During Community Health Improvement Week, the AHA is sharing stories, resources, tools and leadership blogs that reflect on the importance of community and…